148 related articles for article (PubMed ID: 866798)
1. Estramustine phosphate therapy in carcinoma of the prostate.
Andersson L; Edsmyr F; Jönsson G; Könyves I
Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
[TBL] [Abstract][Full Text] [Related]
2. Estramustine phosphate: a specific chemotherapeutic agent?
Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
Nagel R; Kölln CP
Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
[TBL] [Abstract][Full Text] [Related]
4. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
Nilsson T; JONSSON G
Cancer Chemother Rep; 1975; 59(1):229-32. PubMed ID: 1093671
[TBL] [Abstract][Full Text] [Related]
5. Clinical toxicity and long-term results of Emcyt therapy for prostate cancer.
Slack NH; Murphy GP
Urology; 1984 Jun; 23(6 Suppl):73-7. PubMed ID: 6375085
[No Abstract] [Full Text] [Related]
6. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
Jönsson G; Högberg B; Nilsson T
Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
Fosså SD; Miller A
J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
9. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
Mittelman A; Shukla SK; Murphy GP
J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
[TBL] [Abstract][Full Text] [Related]
10. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
Mittelman A; Catane R; Murphy GP
Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
[TBL] [Abstract][Full Text] [Related]
11. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
Catane R; Mittelman A; Kaufman J; Murphy GP
N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
[No Abstract] [Full Text] [Related]
12. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
Balogh F; Kisbenedek L
Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
[TBL] [Abstract][Full Text] [Related]
13. [Estracyt therapy in advanced prostate cancer: current status and personal results].
Nagel R; Leistenschneider W
Urologe A; 1983 May; 22(3):162-6. PubMed ID: 6683899
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
[TBL] [Abstract][Full Text] [Related]
15. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
Fosså SD; Fosså J; Aakvaag A
J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
[TBL] [Abstract][Full Text] [Related]
16. Estramustine phosphate in the treatment of advanced prostatic cancer.
Küss R; Khoury S; Richard F; Fourcade F; Frantz P; Capelle JP
Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
[TBL] [Abstract][Full Text] [Related]
17. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
18. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
Benson RC; Wear JB; Gill GM
J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
[TBL] [Abstract][Full Text] [Related]
19. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
[TBL] [Abstract][Full Text] [Related]
20. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
Chisholm GD; O'Donoghue EP; Kennedy CL
Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
